Protection by WR-2721 of human bone marrow function following irradiation
- 31 August 1986
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 12 (8) , 1505-1508
- https://doi.org/10.1016/0360-3016(86)90204-x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Systemic hemibody irradiation for overt and occult metastasesCancer, 1985
- Phase I trials of WR-2721 and cis-platinumInternational Journal of Radiation Oncology*Biology*Physics, 1984
- Phase I Controlled trials of WR-2721 and cyclophosphamideInternational Journal of Radiation Oncology*Biology*Physics, 1984
- Toxicity of WR-2721 administered in single and multiple dosesInternational Journal of Radiation Oncology*Biology*Physics, 1984
- Radioprotection of two mouse tumors by WR-2721 in single and fractionated treatmentsInternational Journal of Radiation Oncology*Biology*Physics, 1983
- Protection of normal tissues by WR2721 during fractionated irradiationInternational Journal of Radiation Oncology*Biology*Physics, 1976
- Half body radiotherapyInternational Journal of Radiation Oncology*Biology*Physics, 1976
- Radioprotection of tumor and normal tissues by thiophosphate compoundsCancer, 1973
- Radiobiological and Biochemical Studies of Thiophosphate Radioprotective Compounds Related to CysteamineRadiation Research, 1971
- Cysteine Protection against X IrradiationScience, 1949